APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

OTC Gastrointestinal Products

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global OTC Gastrointestinal Products Industry Growth and Trends Forecast to 2032

Report ID 174021070122 December 202590 pages

Choose your research edition.

Industry ResearchOTC Gastrointestinal Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Gastrointestinal Products Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal OTC Gastrointestinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Gastrointestinal Products Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Gastrointestinal Products Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global OTC Gastrointestinal Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for OTC Gastrointestinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for OTC Gastrointestinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Gastrointestinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Gastrointestinal Products include Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global OTC Gastrointestinal Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The OTC Gastrointestinal Products market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OTC Gastrointestinal Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OTC Gastrointestinal Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global OTC Gastrointestinal Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

OTC Gastrointestinal Products Market by Company

Novartis

Merck

Pfizer

GlaxoSmithKline

Bayer

Bristol-Myers Squibb

OTC Gastrointestinal Products Segment by Type

H2 Receptor Antagonists

Proton Pump Inhibitors (PPIs)

OTC Gastrointestinal Products Segment by Application

E-Commerce

Retail Stores

Drug Stores

Hospital Pharmacies

OTC Gastrointestinal Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Gastrointestinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Gastrointestinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Gastrointestinal Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of OTC Gastrointestinal Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of OTC Gastrointestinal Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of H2 Receptor Antagonists Table 2. Major Company of Proton Pump Inhibitors (PPIs) Table 3. Global OTC Gastrointestinal Products Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global OTC Gastrointestinal Products Sales by Type (2021-2026) & (k units) Table 5. Global OTC Gastrointestinal Products Sales Market Share in Volume by Type (2021-2026) Table 6. Global OTC Gastrointestinal Products Sales by Type (2021-2026) & (US$ Million) Table 7. Global OTC Gastrointestinal Products Sales Market Share in Value by Type (2021-2026) Table 8. Global OTC Gastrointestinal Products Price by Type (2021-2026) & (US$/unit) Table 9. Global OTC Gastrointestinal Products Sales by Type (2027-2032) & (k units) Table 10. Global OTC Gastrointestinal Products Sales Market Share in Volume by Type (2027-2032) Table 11. Global OTC Gastrointestinal Products Sales by Type (2027-2032) & (US$ Million) Table 12. Global OTC Gastrointestinal Products Sales Market Share in Value by Type (2027-2032) Table 13. Global OTC Gastrointestinal Products Price by Type (2027-2032) & (US$/unit) Table 14. North America OTC Gastrointestinal Products Sales by Type (2021-2026) & (k units) Table 15. North America OTC Gastrointestinal Products Sales by Type (2021-2026) & (US$ Million) Table 16. Europe OTC Gastrointestinal Products Sales by Type (2021-2026) & (k units) Table 17. Europe OTC Gastrointestinal Products Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific OTC Gastrointestinal Products Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific OTC Gastrointestinal Products Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America OTC Gastrointestinal Products Sales by Type (2021-2026) & (k units) Table 21. Latin America OTC Gastrointestinal Products Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa OTC Gastrointestinal Products Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa OTC Gastrointestinal Products Sales by Type (2021-2026) & (US$ Million) Table 24. OTC Gastrointestinal Products Industry Trends Table 25. OTC Gastrointestinal Products Industry Drivers Table 26. OTC Gastrointestinal Products Industry Opportunities and Challenges Table 27. OTC Gastrointestinal Products Industry Restraints Table 28. Global OTC Gastrointestinal Products Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global OTC Gastrointestinal Products Revenue Market Share by Company (2021-2026) Table 30. Global OTC Gastrointestinal Products Sales by Company (2021-2026) & (k units) Table 31. Global OTC Gastrointestinal Products Sales Share by Company (2021-2026) Table 32. Global OTC Gastrointestinal Products Market Price by Company (2021-2026) & (US$/unit) Table 33. Global OTC Gastrointestinal Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global OTC Gastrointestinal Products Major Company Production Sites and Headquarters Table 35. Global OTC Gastrointestinal Products Company, Product Type & Application Table 36. Global OTC Gastrointestinal Products Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global OTC Gastrointestinal Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global OTC Gastrointestinal Products Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global OTC Gastrointestinal Products Sales by Region (2021-2026) & (k units) Table 41. Global OTC Gastrointestinal Products Sales Market Share in Volume by Region (2021-2026) Table 42. Global OTC Gastrointestinal Products Sales by Region (2021-2026) & (US$ Million) Table 43. Global OTC Gastrointestinal Products Sales Market Share in Value by Region (2021-2026) Table 44. Global OTC Gastrointestinal Products Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global OTC Gastrointestinal Products Sales by Region (2027-2032) & (k units) Table 46. Global OTC Gastrointestinal Products Sales Market Share in Volume by Region (2027-2032) Table 47. Global OTC Gastrointestinal Products Sales by Region (2027-2032) & (US$ Million) Table 48. Global OTC Gastrointestinal Products Sales Market Share in Value by Region (2027-2032) Table 49. Global OTC Gastrointestinal Products Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global OTC Gastrointestinal Products Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global OTC Gastrointestinal Products Sales by Application (2021-2026) & (k units) Table 52. Global OTC Gastrointestinal Products Sales Market Share in Volume by Application (2021-2026) Table 53. Global OTC Gastrointestinal Products Sales by Application (2021-2026) & (US$ Million) Table 54. Global OTC Gastrointestinal Products Sales Market Share in Value by Application (2021-2026) Table 55. Global OTC Gastrointestinal Products Price by Application (2021-2026) & (US$/unit) Table 56. Global OTC Gastrointestinal Products Sales by Application (2027-2032) & (k units) Table 57. Global OTC Gastrointestinal Products Sales Market Share in Volume by Application (2027-2032) Table 58. Global OTC Gastrointestinal Products Sales by Application (2027-2032) & (US$ Million) Table 59. Global OTC Gastrointestinal Products Sales Market Share in Value by Application (2027-2032) Table 60. Global OTC Gastrointestinal Products Price by Application (2027-2032) & (US$/unit) Table 61. North America OTC Gastrointestinal Products Sales by Application (2021-2026) & (k units) Table 62. North America OTC Gastrointestinal Products Sales by Application (2021-2026) & (US$ Million) Table 63. Europe OTC Gastrointestinal Products Sales by Application (2021-2026) & (k units) Table 64. Europe OTC Gastrointestinal Products Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific OTC Gastrointestinal Products Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific OTC Gastrointestinal Products Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America OTC Gastrointestinal Products Sales by Application (2021-2026) & (k units) Table 68. Latin America OTC Gastrointestinal Products Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa OTC Gastrointestinal Products Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa OTC Gastrointestinal Products Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis OTC Gastrointestinal Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis OTC Gastrointestinal Products Product Portfolio Table 75. Novartis Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck OTC Gastrointestinal Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck OTC Gastrointestinal Products Product Portfolio Table 80. Merck Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer OTC Gastrointestinal Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pfizer OTC Gastrointestinal Products Product Portfolio Table 85. Pfizer Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline OTC Gastrointestinal Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline OTC Gastrointestinal Products Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Bayer Company Information Table 92. Bayer Business Overview Table 93. Bayer OTC Gastrointestinal Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Bayer OTC Gastrointestinal Products Product Portfolio Table 95. Bayer Recent Development Table 96. Bristol-Myers Squibb Company Information Table 97. Bristol-Myers Squibb Business Overview Table 98. Bristol-Myers Squibb OTC Gastrointestinal Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolio Table 100. Bristol-Myers Squibb Recent Development Table 101. North America OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. North America OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 103. North America OTC Gastrointestinal Products Sales Market Share by Country (2021-2026) Table 104. North America OTC Gastrointestinal Products Sales Forecast by Country (2027-2032) & (k units) Table 105. North America OTC Gastrointestinal Products Sales Market Share Forecast by Country (2027-2032) Table 106. North America OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America OTC Gastrointestinal Products Market Size by Country (2021-2026) & (US$ Million) Table 108. North America OTC Gastrointestinal Products Market Share by Country (2021-2026) Table 109. North America OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America OTC Gastrointestinal Products Market Share Forecast by Country (2027-2032) Table 111. Europe OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Europe OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 113. Europe OTC Gastrointestinal Products Sales Market Share by Country (2021-2026) Table 114. Europe OTC Gastrointestinal Products Sales Forecast by Country (2027-2032) & (k units) Table 115. Europe OTC Gastrointestinal Products Sales Market Share Forecast by Country (2027-2032) Table 116. Europe OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe OTC Gastrointestinal Products Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe OTC Gastrointestinal Products Market Share by Country (2021-2026) Table 119. Europe OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe OTC Gastrointestinal Products Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 123. Asia-Pacific OTC Gastrointestinal Products Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific OTC Gastrointestinal Products Sales Forecast by Country (2027-2032) & (k units) Table 125. Asia-Pacific OTC Gastrointestinal Products Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific OTC Gastrointestinal Products Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific OTC Gastrointestinal Products Market Share by Country (2021-2026) Table 129. Asia-Pacific OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific OTC Gastrointestinal Products Market Share Forecast by Country (2027-2032) Table 131. Latin America OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Latin America OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 133. Latin America OTC Gastrointestinal Products Sales Market Share by Country (2021-2026) Table 134. Latin America OTC Gastrointestinal Products Sales Forecast by Country (2027-2032) & (k units) Table 135. Latin America OTC Gastrointestinal Products Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America OTC Gastrointestinal Products Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America OTC Gastrointestinal Products Market Share by Country (2021-2026) Table 139. Latin America OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America OTC Gastrointestinal Products Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa OTC Gastrointestinal Products Sales by Country (2021-2026) & (k units) Table 143. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa OTC Gastrointestinal Products Sales Forecast by Country (2027-2032) & (k units) Table 145. Middle East and Africa OTC Gastrointestinal Products Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa OTC Gastrointestinal Products Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa OTC Gastrointestinal Products Market Share by Country (2021-2026) Table 149. Middle East and Africa OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa OTC Gastrointestinal Products Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. OTC Gastrointestinal Products Distributors List Table 154. OTC Gastrointestinal Products Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. OTC Gastrointestinal Products Image Figure 2. Global OTC Gastrointestinal Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Gastrointestinal Products Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Gastrointestinal Products Sales (2021-2032) & (k units) Figure 5. H2 Receptor Antagonists Image Figure 6. Global H2 Receptor Antagonists Sales YoY Growth (2021-2032) & (k units) Figure 7. Proton Pump Inhibitors (PPIs) Image Figure 8. Global Proton Pump Inhibitors (PPIs) Sales YoY Growth (2021-2032) & (k units) Figure 9. Global OTC Gastrointestinal Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global OTC Gastrointestinal Products Market Share by Type 2025 VS 2032 Figure 11. North America OTC Gastrointestinal Products Sales Market Share in Volume by Type in 2025 Figure 12. North America OTC Gastrointestinal Products Sales Market Share in Value by Type in 2025 Figure 13. Europe OTC Gastrointestinal Products Sales Market Share in Volume by Type in 2025 Figure 14. Europe OTC Gastrointestinal Products Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific OTC Gastrointestinal Products Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific OTC Gastrointestinal Products Sales Market Share in Value by Type in 2025 Figure 17. Latin America OTC Gastrointestinal Products Sales Market Share in Volume by Type in 2025 Figure 18. Latin America OTC Gastrointestinal Products Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa OTC Gastrointestinal Products Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa OTC Gastrointestinal Products Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 OTC Gastrointestinal Products Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. E-Commerce Image Figure 24. Global E-Commerce Sales YoY Growth (2021-2032) & (k units) Figure 25. Retail Stores Image Figure 26. Global Retail Stores Sales YoY Growth (2021-2032) & (k units) Figure 27. Drug Stores Image Figure 28. Global Drug Stores Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Global OTC Gastrointestinal Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global OTC Gastrointestinal Products Market Share by Application 2025 VS 2032 Figure 33. North America OTC Gastrointestinal Products Sales Market Share in Volume by Application in 2025 Figure 34. North America OTC Gastrointestinal Products Sales Market Share in Value by Application in 2025 Figure 35. Europe OTC Gastrointestinal Products Sales Market Share in Volume by Application in 2025 Figure 36. Europe OTC Gastrointestinal Products Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific OTC Gastrointestinal Products Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific OTC Gastrointestinal Products Sales Market Share in Value by Application in 2025 Figure 39. Latin America OTC Gastrointestinal Products Sales Market Share in Volume by Application in 2025 Figure 40. Latin America OTC Gastrointestinal Products Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa OTC Gastrointestinal Products Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa OTC Gastrointestinal Products Sales Market Share in Value by Application in 2025 Figure 43. North America OTC Gastrointestinal Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America OTC Gastrointestinal Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America OTC Gastrointestinal Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe OTC Gastrointestinal Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe OTC Gastrointestinal Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe OTC Gastrointestinal Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific OTC Gastrointestinal Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific OTC Gastrointestinal Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific OTC Gastrointestinal Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America OTC Gastrointestinal Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America OTC Gastrointestinal Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America OTC Gastrointestinal Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa OTC Gastrointestinal Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa OTC Gastrointestinal Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa OTC Gastrointestinal Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa OTC Gastrointestinal Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. OTC Gastrointestinal Products Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. OTC Gastrointestinal Products Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Receptor Antagonists
  • Proton Pump Inhibitors (PPIs)
Applications
  • E-Commerce
  • Retail Stores
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global OTC Gastrointestinal Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global OTC Gastrointestinal Products Sales Estimates and Forecasts (2021-2032)
  5. 1.3 OTC Gastrointestinal Products Market by Type
  6. 1.3.1 H2 Receptor Antagonists
  7. 1.3.2 Proton Pump Inhibitors (PPIs)
  8. 1.4 Global OTC Gastrointestinal Products Market Size by Type
  9. 1.4.1 Global OTC Gastrointestinal Products Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global OTC Gastrointestinal Products Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global OTC Gastrointestinal Products Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America OTC Gastrointestinal Products Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe OTC Gastrointestinal Products Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific OTC Gastrointestinal Products Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America OTC Gastrointestinal Products Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa OTC Gastrointestinal Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 OTC Gastrointestinal Products Industry Trends
  2. 2.2 OTC Gastrointestinal Products Industry Drivers
  3. 2.3 OTC Gastrointestinal Products Industry Opportunities and Challenges
  4. 2.4 OTC Gastrointestinal Products Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by OTC Gastrointestinal Products Revenue (2021-2026)
  2. 3.2 Global Top Players by OTC Gastrointestinal Products Sales (2021-2026)
  3. 3.3 Global Top Players by OTC Gastrointestinal Products Price (2021-2026)
  4. 3.4 Global OTC Gastrointestinal Products Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global OTC Gastrointestinal Products Major Company Production Sites & Headquarters
  6. 3.6 Global OTC Gastrointestinal Products Company, Product Type & Application
  7. 3.7 Global OTC Gastrointestinal Products Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global OTC Gastrointestinal Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 OTC Gastrointestinal Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 OTC Gastrointestinal Products Tier 1, Tier 2, and Tier 3
4 OTC Gastrointestinal Products Regional Status and Outlook
  1. 4.1 Global OTC Gastrointestinal Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global OTC Gastrointestinal Products Historic Market Size by Region
  3. 4.2.1 Global OTC Gastrointestinal Products Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global OTC Gastrointestinal Products Sales in Value by Region (2021-2026)
  5. 4.2.3 Global OTC Gastrointestinal Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global OTC Gastrointestinal Products Forecasted Market Size by Region
  7. 4.3.1 Global OTC Gastrointestinal Products Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global OTC Gastrointestinal Products Sales in Value by Region (2027-2032)
  9. 4.3.3 Global OTC Gastrointestinal Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 OTC Gastrointestinal Products by Application
  1. 5.1 OTC Gastrointestinal Products Market by Application
  2. 5.1.1 E-Commerce
  3. 5.1.2 Retail Stores
  4. 5.1.3 Drug Stores
  5. 5.1.4 Hospital Pharmacies
  6. 5.2 Global OTC Gastrointestinal Products Market Size by Application
  7. 5.2.1 Global OTC Gastrointestinal Products Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global OTC Gastrointestinal Products Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global OTC Gastrointestinal Products Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America OTC Gastrointestinal Products Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe OTC Gastrointestinal Products Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific OTC Gastrointestinal Products Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America OTC Gastrointestinal Products Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa OTC Gastrointestinal Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis OTC Gastrointestinal Products Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck OTC Gastrointestinal Products Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer OTC Gastrointestinal Products Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline OTC Gastrointestinal Products Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer OTC Gastrointestinal Products Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Bristol-Myers Squibb
  32. 6.6.1 Bristol-Myers Squibb Company Information
  33. 6.6.2 Bristol-Myers Squibb Business Overview
  34. 6.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolio
  36. 6.6.5 Bristol-Myers Squibb Recent Developments
7 North America by Country
  1. 7.1 North America OTC Gastrointestinal Products Sales by Country
  2. 7.1.1 North America OTC Gastrointestinal Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America OTC Gastrointestinal Products Sales by Country (2021-2026)
  4. 7.1.3 North America OTC Gastrointestinal Products Sales Forecast by Country (2027-2032)
  5. 7.2 North America OTC Gastrointestinal Products Market Size by Country
  6. 7.2.1 North America OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America OTC Gastrointestinal Products Market Size by Country (2021-2026)
  8. 7.2.3 North America OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe OTC Gastrointestinal Products Sales by Country
  2. 8.1.1 Europe OTC Gastrointestinal Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe OTC Gastrointestinal Products Sales by Country (2021-2026)
  4. 8.1.3 Europe OTC Gastrointestinal Products Sales Forecast by Country (2027-2032)
  5. 8.2 Europe OTC Gastrointestinal Products Market Size by Country
  6. 8.2.1 Europe OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe OTC Gastrointestinal Products Market Size by Country (2021-2026)
  8. 8.2.3 Europe OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific OTC Gastrointestinal Products Sales by Country
  2. 9.1.1 Asia-Pacific OTC Gastrointestinal Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific OTC Gastrointestinal Products Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific OTC Gastrointestinal Products Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific OTC Gastrointestinal Products Market Size by Country
  6. 9.2.1 Asia-Pacific OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific OTC Gastrointestinal Products Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America OTC Gastrointestinal Products Sales by Country
  2. 10.1.1 South America OTC Gastrointestinal Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America OTC Gastrointestinal Products Sales by Country (2021-2026)
  4. 10.1.3 South America OTC Gastrointestinal Products Sales Forecast by Country (2027-2032)
  5. 10.2 South America OTC Gastrointestinal Products Market Size by Country
  6. 10.2.1 South America OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America OTC Gastrointestinal Products Market Size by Country (2021-2026)
  8. 10.2.3 South America OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa OTC Gastrointestinal Products Sales by Country
  2. 11.1.1 Middle East and Africa OTC Gastrointestinal Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa OTC Gastrointestinal Products Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa OTC Gastrointestinal Products Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa OTC Gastrointestinal Products Market Size by Country
  6. 11.2.1 Middle East and Africa OTC Gastrointestinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa OTC Gastrointestinal Products Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa OTC Gastrointestinal Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 OTC Gastrointestinal Products Value Chain Analysis
  2. 12.1.1 OTC Gastrointestinal Products Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 OTC Gastrointestinal Products Production Mode & Process
  7. 12.2 OTC Gastrointestinal Products Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 OTC Gastrointestinal Products Distributors
  10. 12.2.3 OTC Gastrointestinal Products Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst